Free Trial

BioRestorative Therapies (BRTX) Competitors

BioRestorative Therapies logo
$1.60 +0.05 (+2.90%)
Closing price 05/22/2025 03:55 PM Eastern
Extended Trading
$1.60 0.00 (0.00%)
As of 05/22/2025 05:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BRTX vs. BDSX, CCM, BMGL, BNR, MRAI, ENZ, MGRX, OTRK, SSY, and BGLC

Should you be buying BioRestorative Therapies stock or one of its competitors? The main competitors of BioRestorative Therapies include Biodesix (BDSX), Concord Medical Services (CCM), Basel Medical Group (BMGL), Burning Rock Biotech (BNR), Marpai (MRAI), Enzo Biochem (ENZ), Mangoceuticals (MGRX), Ontrak (OTRK), SunLink Health Systems (SSY), and BioNexus Gene Lab (BGLC). These companies are all part of the "healthcare" industry.

BioRestorative Therapies vs.

Biodesix (NASDAQ:BDSX) and BioRestorative Therapies (NASDAQ:BRTX) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their community ranking, dividends, profitability, media sentiment, institutional ownership, risk, analyst recommendations, earnings and valuation.

In the previous week, Biodesix had 5 more articles in the media than BioRestorative Therapies. MarketBeat recorded 9 mentions for Biodesix and 4 mentions for BioRestorative Therapies. Biodesix's average media sentiment score of -0.48 beat BioRestorative Therapies' score of -0.60 indicating that Biodesix is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Biodesix
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
BioRestorative Therapies
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Negative

Biodesix has a net margin of -66.84% compared to BioRestorative Therapies' net margin of -2,697.08%. BioRestorative Therapies' return on equity of -98.49% beat Biodesix's return on equity.

Company Net Margins Return on Equity Return on Assets
Biodesix-66.84% -275.79% -43.05%
BioRestorative Therapies -2,697.08%-98.49%-75.23%

Biodesix currently has a consensus price target of $1.75, indicating a potential upside of 391.71%. BioRestorative Therapies has a consensus price target of $18.00, indicating a potential upside of 1,028.53%. Given BioRestorative Therapies' stronger consensus rating and higher probable upside, analysts plainly believe BioRestorative Therapies is more favorable than Biodesix.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biodesix
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
BioRestorative Therapies
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

BioRestorative Therapies has lower revenue, but higher earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than BioRestorative Therapies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biodesix$71.32M0.73-$52.15M-$0.29-1.23
BioRestorative Therapies$401K29.85-$14.41M-$1.47-1.09

Biodesix has a beta of 1.18, meaning that its share price is 18% more volatile than the S&P 500. Comparatively, BioRestorative Therapies has a beta of 77.73, meaning that its share price is 7,673% more volatile than the S&P 500.

Biodesix received 33 more outperform votes than BioRestorative Therapies when rated by MarketBeat users. However, 100.00% of users gave BioRestorative Therapies an outperform vote while only 76.09% of users gave Biodesix an outperform vote.

CompanyUnderperformOutperform
BiodesixOutperform Votes
35
76.09%
Underperform Votes
11
23.91%
BioRestorative TherapiesOutperform Votes
2
100.00%
Underperform Votes
No Votes

21.0% of Biodesix shares are owned by institutional investors. Comparatively, 69.4% of BioRestorative Therapies shares are owned by institutional investors. 69.2% of Biodesix shares are owned by company insiders. Comparatively, 25.5% of BioRestorative Therapies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Biodesix beats BioRestorative Therapies on 10 of the 18 factors compared between the two stocks.

Get BioRestorative Therapies News Delivered to You Automatically

Sign up to receive the latest news and ratings for BRTX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BRTX vs. The Competition

MetricBioRestorative Therapieshealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ Exchange
Market Cap$11.97M$2.03B$5.33B$8.39B
Dividend YieldN/A6.96%5.21%4.11%
P/E Ratio-1.0415.8626.7919.70
Price / Sales29.853.54393.69121.79
Price / CashN/A9.3238.2534.62
Price / Book0.653.926.774.50
Net Income-$14.41M$87.49M$3.23B$248.22M
7 Day Performance-0.93%-4.19%0.42%-0.80%
1 Month Performance-7.80%-6.42%9.06%11.52%
1 Year Performance20.83%-28.11%18.55%8.99%

BioRestorative Therapies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BRTX
BioRestorative Therapies
3.3303 of 5 stars
$1.60
+2.9%
$18.00
+1,028.5%
+19.0%$11.97M$401,000.00-1.047
BDSX
Biodesix
3.2717 of 5 stars
$0.28
-7.9%
$2.00
+621.2%
-76.6%$40.64M$71.32M-0.71220Analyst Forecast
Gap Down
CCM
Concord Medical Services
N/A$8.39
-0.7%
N/A+56.4%$36.43M$383.96M0.00970
BMGL
Basel Medical Group
N/A$1.97
-7.5%
N/AN/A$36.36M$10.05M0.0036News Coverage
High Trading Volume
BNR
Burning Rock Biotech
0.4525 of 5 stars
$2.95
+8.5%
N/A-56.2%$31.75M$515.82M-0.981,390Upcoming Earnings
Gap Down
MRAI
Marpai
N/A$1.16
-3.9%
N/A-33.4%$17.32M$34.87M-0.44150Gap Down
ENZ
Enzo Biochem
N/A$0.33
-14.8%
N/A-69.3%$17.03M$29.09M0.00520Gap Down
High Trading Volume
MGRX
Mangoceuticals
0.1864 of 5 stars
$1.50
-0.3%
N/A-98.4%$7.76M$615,873.00-0.263Positive News
OTRK
Ontrak
2.5034 of 5 stars
$1.56
-1.6%
$45.00
+2,793.9%
-60.9%$6.56M$10.85M-0.15250Positive News
Earnings Report
SSY
SunLink Health Systems
N/A$0.86
flat
N/A+41.8%$6.06M$31.23M6.141,376Analyst Forecast
BGLC
BioNexus Gene Lab
0.2628 of 5 stars
$2.72
+1.1%
N/A-48.2%$4.89M$9.51M0.0030News Coverage
Positive News

Related Companies and Tools


This page (NASDAQ:BRTX) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners